-

Imperative Care Announces Appointment of Todd Van Horn to Chief Financial Officer

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. today announced the appointment of Todd Van Horn as Chief Financial Officer.

“Imperative Care is deeply committed to bringing together a strong balance of leaders with complementary expertise and a shared passion for elevating patient care,” said Fred Khosravi, CEO of Imperative Care. “We are very pleased to welcome Todd at this important moment for Imperative Care, as we strengthen our financial position and focus on scaling our hypergrowth thrombectomy technologies to address runaway clot throughout the body and bring better care to more patients globally.”

Mr. Van Horn brings more than two decades of leadership experience in finance, business development, strategy, operations, and organizational transformation at global medical device and life sciences companies. Most recently, he served as Chief Operating Officer and then, Chief Business Officer at Candela Medical, where he led the operational aspects of a comprehensive turnaround that improved growth, focused strategy, and increased profit margins. Prior to Candela, Mr. Van Horn served in roles of increasing responsibility at Cord Blood Registry, most recently as its General Manager, both when it was an independent company and as a subsidiary of AMAG Pharmaceuticals.

“Imperative Care has brought forward transformative technologies to address stroke and vascular disease, creating meaningful improvements in patient outcomes,” said Mr. Van Horn. “I am very excited to be joining the Imperative Care leadership team to help position the company for the future and grow its global impact on patient care.”

Mr. Van Horn spent the first decade of his career investing in and advising life science and healthcare businesses as a private equity investor at Linden Capital Partners and prior to that as an investment banker. He holds an MBA from Northwestern University’s Kellogg School of Management and a Bachelor of Science in Molecular, Cell, and Developmental Biology from UCLA.

About Imperative Care, Inc.

Imperative Care is a commercial-stage medical technology company researching, developing and manufacturing connected innovations to elevate care for people affected by devastating vascular diseases such as stroke and pulmonary embolism. The company is addressing specific gaps in treatment and care to make an impact across the entire patient journey. Imperative Care is based in Campbell, Calif. https://imperativecare.com.

Contacts

Investor Contact:
Phil Nalbone
Vice President of Corporate Development and Investor Relations
Imperative Care, Inc.
Pnalbone@imperativecare.com

Media Contact:
Jana Chow
Imperative Care, Inc.
925-324-9846
jchow@imperativecare.com

Imperative Care, Inc.


Release Summary
Imperative Care, Inc. announces the appointment of Todd Van Horn as Chief Financial Officer.
Release Versions

Contacts

Investor Contact:
Phil Nalbone
Vice President of Corporate Development and Investor Relations
Imperative Care, Inc.
Pnalbone@imperativecare.com

Media Contact:
Jana Chow
Imperative Care, Inc.
925-324-9846
jchow@imperativecare.com

More News From Imperative Care, Inc.

Imperative Care Presents Positive Real-World Data from Ischemic Stroke Patients Treated with ADAPT 2.0 Using the Zoom Stroke System

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care announces late-breaking, real-world data from a multi-center review of ischemic stroke patients treated with ADAPT 2.0....

Imperative Care Announces Late-Breaking Data Presentation and Peer-Reviewed Publication from Pivotal Trial of Symphony Thrombectomy System in Patients with Acute Pulmonary Embolism

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. announces positive results from the SYMPHONY-PE Trial evaluating Symphony® Thrombectomy System in the treatment of acute PE....

Imperative Care Announces FDA Clearance of Symphony Thrombectomy System, the First Large-Bore Continuous Vacuum System for Treatment of Pulmonary Embolism

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. announces FDA 510(k) clearance of its Symphony® Thrombectomy System to treat pulmonary embolism (PE)....
Back to Newsroom